Referanslar

1. Sampson HA, Muñoz-Furlong A, Campbell RL, et al. Second symposium on the definition and management of anaphylaxis: Summary report - Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. J Allergy Clin Immunol. 2006;117(2):391-7. [Crossref]  [PubMed]
2. Simons FE, Ardusso LR, Bilò MB, et al. 2012 Update: World Allergy Organization Guidelines for the assessment and management of anaphylaxis. Curr Opin Allergy Clin Immunol. 2012;12(4):389-99. [Crossref]  [PubMed]
3. Waterfield T, Dyer E, Wilson K, Boyle RJ. How to interpret mast cell tests. Arch Dis Child Educ Pract Ed. 2016;101(5):246-51. [Crossref]  [PubMed]
4. Analysis of MC(T) and MC(TC) mast cells in tissue. - PubMed - NCBI. Accessed May 16, 2020. [PubMed]
5. Markers of mast cell degranulation. - PubMed - NCBI. Accessed May 16, 2020. [PubMed]
6. Irani AA, Garriga MM, Metcalfe DD, Schwartz LB. Mast cells in cutaneous mastocytosis: accumulation of the MCTC type. Clin Exp Allergy. 1990;20(1):53-8. [Crossref]  [PubMed]
7. Krishnaswamy G, Kelley J, Johnson D, et al. The human mast cell: functions in physiology and disease. Front Biosci. 2001;6. [Crossref]  [PubMed]
8. Dvorak AM, McLeod RS, Ondcrdonk A, et al. Ultrastructural Evidence for Piecemeal and Anaphylactic Degranulation of Human Gut Mucosal Mast Cells in vivo. Int Arch Allergy Immunol. 1992;99(1):74-83. [Crossref]  [PubMed]
9. McNeil HP, Adachi R, Stevens RL. Mast cellrestricted tryptases: Structure and function in inflammation and pathogen defense. J Biol Chem. 2007;282(29):20785-9. [Crossref]  [PubMed]
10. Castells MC, Irani AM, Schwartz LB. Evaluation of human peripheral blood leukocytes for mast cell tryptase. J Immunol. 1987;138(7): 2184-9. [Crossref]  [PubMed]
11. Schwartz LB, Irani AM, Roller K, Castells MC, Schechter NM. Quantitation of histamine, tryptase, and chymase in dispersed human T and TC mast cells. J Immunol. 1987;138(8):2611-5. [Crossref]  [PubMed]
12. Signal transduction and cytokine production by human basophils. - PubMed - NCBI. Accessed May 16, 2020. [PubMed]
13. Michalska-Krzanowska G. Tryptase in diagnosing adverse suspected anaphylactic reaction. Adv Clin Exp Med. 2012;21(3):403-8.
14. Lieberman P, Nicklas RA, Oppenheimer J, et al. The diagnosis and management of anaphylaxis practice parameter: 2010 Update. J Allergy Clin Immunol. 2010;126(3). [Crossref]  [PubMed]
15. Vitte J. Human mast cell tryptase in biology and medicine. Mol Immunol. 2015;63(1):18-24. [Crossref]  [PubMed]
16. Sala-Cunill A, Cardona V, Labrador-Horrillo M, et al. Usefulness and limitations of sequential serum tryptase for the diagnosis of anaphylaxis in 102 patients. Int Arch Allergy Immunol. 2013;160(2):192-9. [Crossref]  [PubMed]
17. Elevated postmortem tryptase in the absence of anaphylaxis. -PubMed-NCBI. Accessed May 16, 2020. [PubMed]
18. Edston E, Van Hage-Hamsten M. β-Tryptase measurements post-mortem in anaphylactic deaths and in controls. Forensic Sci Int. 1998;93(2-3):135-42. [Crossref]  [PubMed]
19. Valent P, Akin C, Arock M, et al. Definitions, criteria and global classification of mast cell disorders with special reference to mast cell activation syndromes: A consensus proposal. Int Arch Allergy Immunol. 2012;157(3):215-25. [Crossref]  [PubMed]  [PMC]
20. Schwartz LB, Yunginger JW, Bokhari R, Dull D. Time course of appearance and disappearance of human mast cell tryptase in the circulation after anaphylaxis. J Clin Invest. 1989;83(5):1551-5. [Crossref]  [PubMed]  [PMC]
21. Stone SF, Cotterell C, Isbister GK, Holdgate A, Brown SGA. Elevated serum cytokines during human anaphylaxis: Identification of potential mediators of acute allergic reactions. J Allergy Clin Immunol. 2009;124(4). [Crossref]  [PubMed]
22. Haeberli G, Brönnimann M, Hunziker T, Müller U. Elevated basal serum tryptase and hymenoptera venom allergy: Relation to severity of sting reactions and to safety and efficacy of venom immunotherapy. Clin Exp Allergy. 2003;33(9):1216-20. [Crossref]  [PubMed]
23. Ruëff F, Przybilla B, Biló MB, et al. Predictors of side effects during the buildup phase of venom immunotherapy for Hymenoptera venom allergy: The importance of baseline serum tryptase†. J Allergy Clin Immunol. 2010;126(1). [Crossref]  [PubMed]
24. McLean-Tooke A, Goulding M, Bundell C, White J, Hollingsworth P. Postmortem serum tryptase levels in anaphylactic and non-anaphylactic deaths. J Clin Pathol. 2014;67(2):134-8. [Crossref]  [PubMed]
25. Buckley MG, Variend S, Walls AF. Elevated serum concentrations of β-tryptase, but not αtryptase, in Sudden Infant Death Syndrome (SIDS). An investigation of anaphylactic mechanisms. Clin Exp Allergy. 2001;31(11):1696- 704. [Crossref]  [PubMed]
26. Ruëff F, Friedl T, Arnold A, Kramer M, Przybilla B. Release of mast cell tryptase into saliva: A tool to diagnose food allergy by a mucosal challenge test? Int Arch Allergy Immunol. 2011;155(3):282-8. [Crossref]  [PubMed]
27. Prieto-García A, Castells MC, Hansbro PM, Stevens RL. Mast cell-restricted tetramerforming tryptases and their beneficial roles in hemostasis and blood coagulation. Immunol Allergy Clin North Am. 2014;34(2):263-81. [Crossref]  [PubMed]
28. Jones BL, Kearns GL. Histamine: New thoughts about a familiar mediator. Clin Pharmacol Ther. 2011;89(2):189-97. [Crossref]  [PubMed]
29. Takeda J, Ueda E, Takahashi J, Fukushima K. Plasma N-methylhistamine concentration as an indicator of histamine release by intravenous d-tubocurarine in humans: Preliminary study in five patients by radioimmunoassay kits. Anesth Analg. 1995;80(5):1015-7. [Crossref]  [PubMed]
30. Oosting E, Keyzer JJ, Wolthers BG. Correlation between urinary levels of histamine metabolites in 24-hour urine and morning urine samples of man: Influence of histaminerich food. Agents Actions. 1989;27(1-2):205- 7. [Crossref]  [PubMed]
31. Satomura K, Shimizu S, Nagato T, et al. Establishment of an assay method for human mast cell chymase. Hepatol Res. 2002;24(4):361-7. [Crossref]  [PubMed]
32. Nishio H, Takai S, Miyazaki M, et al. Usefulness of serum mast cell-specific chymase levels for postmortem diagnosis of anaphylaxis. Int J Legal Med. 2005;119(6):331-4. [Crossref]  [PubMed]
33. Zhou X, Buckley MG, Lau LC, Summers C, Pumphrey RS, Walls AF. Mast Cell Carboxypeptidase as a New Clinical Marker for Anaphylaxis. J Allergy Clin Immunol. 2006;117(2):S85. - [Crossref]
34. Lieberman P, Garvey LH. Mast Cells and Anaphylaxis. Curr Allergy Asthma Rep. 2016;16(3):1-7. [Crossref]  [PubMed]
35. Simons FE, Ebisawa M, Sanchez-Borges M, et al. 2015 update of the evidence base: World Allergy Organization anaphylaxis guidelines. World Allergy Organ J. 2015;8(1). [Crossref]  [PubMed]  [PMC]
36. Brown SGA, Stone SF, Fatovich DM, et al. Anaphylaxis: Clinical patterns, mediator release, and severity. J Allergy Clin Immunol. 2013;132(5). [Crossref]  [PubMed]
37. Sala-Cunill A, Björkqvist J, Senter R, et al. Plasma contact system activation drives anaphylaxis in severe mast cell-mediated allergic reactions. J Allergy Clin Immunol. 2015;135(4):1031-43.e6. [Crossref]  [PubMed]
38. Ono E, Taniguchi M, Mita H, et al. Increased production of cysteinyl leukotrienes and prostaglandin D2 during human anaphylaxis. Clin Exp Allergy. 2009;39(1):72-80. [Crossref]  [PubMed]
39. Adkinson N, Bochner B, Busse W, Holgate S, Lemanske R, Simons F. Middleton's Allergy Principles and Practice. 7th ed. 2009.
40. Austen KF. From slow-reacting substance of anaphylaxis to leukotriene c4 synthase. Int Arch Allergy Immunol. 1995;107(1-3):19-24. [Crossref]  [PubMed]
41. Nassiri M, Eckermann O, Babina M, Edenharter G, Worm M. Serum levels of 9α,11βPGF2 and cysteinyl leukotrienes are useful biomarkers of anaphylaxis. J Allergy Clin Immunol. 2016;137(1):312-4.e7. [Crossref]  [PubMed]
42. Mast cell mediators prostaglandin-D2 and histamine activate human eosinophils. - PubMed - NCBI. Accessed May 16, 2020. [PubMed]
43. Awad JA, Morrow JD, Roberts LJ. Detection of the major urinary metabolite of prostaglandin D2 in the circulation: Demonstration of elevated levels in patients with disorders of systemic mast cell activation. J Allergy Clin Immunol. 1994;93(5):817-24. [Crossref]  [PubMed]
44. Finkelman FD. Anaphylaxis: Lessons from mouse models. J Allergy Clin Immunol. 2007;120(3):506-15. [Crossref]  [PubMed]
45. Karasawa K. Clinical aspects of plasma platelet-activating factor-acetylhydrolase. Biochim Biophys Acta - Mol Cell Biol Lipids. 2006;1761(11):1359-72. [Crossref]  [PubMed]
46. Cytokine enhancement of anaphylaxis. - PubMed - NCBI. Accessed May 16, 2020. [PubMed]
47. Vadas P, Perelman B, Liss G. Platelet-activating factor, histamine, and tryptase levels in human anaphylaxis. J Allergy Clin Immunol. 2013;131(1):144-9. [Crossref]  [PubMed]
48. Vadas P, Gold M, Perelman B, et al. PlateletActivating Factor, PAF acetylhydrolase, and severe anaphylaxis. N Engl J Med. 2008;358(1):28-35. [Crossref]  [PubMed]
49. Perelman B, Adil A, Vadas P. Relationship between platelet activating factor acetylhydrolase activity and apolipoprotein B levels in patients with peanut allergy. Allergy, Asthma Clin Immunol. 2014;10(1). [Crossref]  [PubMed]  [PMC]
50. Pravettoni V, Piantanida M, Primavesi L, Forti S, Pastorello EA. Basal platelet-activating factor acetylhydrolase: Prognostic marker of severe Hymenoptera venom anaphylaxis. J Allergy Clin Immunol. 2014;133(4):1218-20. [Crossref]  [PubMed]
51. Oskeritzian CA, Price MM, Hait NC, et al. Essential roles of sphingosine-1-phosphate receptor 2 in human mast cell activation, anaphylaxis, and pulmonary edema. J Exp Med. 2010;207(3):465-74. [Crossref]  [PubMed]  [PMC]
52. Niki T, Tsutsui S, Hirose S, et al. Galectin-9 is a high affinity IgE-binding lectin with anti-allergic effect by blocking IgE-antigen complex formation. J Biol Chem. 2009;284(47):32344- 52. [Crossref]  [PubMed]  [PMC]
53. Expression of inducible nitric oxide synthase in a mouse model of anaphylaxis. - PubMed - NCBI. Accessed May 16, 2020. [PubMed]
54. Hsu CL, Neilsen CV, Bryce PJ. IL-33 is produced by mast cells and regulates IgE-dependent inflammation. PLoS One. 2010;5(8). [Crossref]  [PubMed]  [PMC]
55. Akin C, Scott LM, Kocabas CN, et al. Demonstration of an aberrant mast-cell population with clonal markers in a subset of patients with "idiopathic" anaphylaxis. Blood. 2007;110(7): 2331-3. [Crossref]  [PubMed]  [PMC]